Early experience with robotic central pancreatectomy with patient-reported outcomes and comparison with open central pancreatectomy.


Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 16 03 2023
accepted: 20 03 2023
medline: 13 6 2023
pubmed: 7 4 2023
entrez: 6 4 2023
Statut: ppublish

Résumé

Robotic central pancreatectomy (CP) has emerged in recent years as a noninferior approach to open CP and may offer improved patient-reported outcomes and reduction in incisional hernias. All patients who underwent open and robotic CP between (2013 and 2022) were selected, and perioperative outcomes were analyzed. Patients who underwent robotic CP were interviewed over the phone to assess patient-reported postoperative outcomes. A total of 18 CP operations (56%-open vs. 44%-robotic) were identified. The overall median age was 67 years (interquartile range: 60-72), and 50% (n = 9) of patients were female. Median length of surgery was statistically longer for robotic CP (411 vs. 138 min, p = 0.002); all other intraoperative variables were similar. Postoperatively, a similar number of patients in the open and robotic cohorts developed clinically significant postoperative pancreatic fistulas (37.5% vs. 30%, p = 1) and major complications (37.5% vs. 20%, p = 0.60), respectively. No patients in the robotic cohort developed an incisional hernia, compared to 40% (n = 4) in open (p = 0.08). All patients returned to a baseline level of activity and reported a high quality of life. With the exception of longer operative times, robotic CP is a noninferior, definitive resection technique for select lesions of the middle pancreas. Additionally, the robotic approach may result in a reduction in incisional hernia development.

Sections du résumé

BACKGROUND BACKGROUND
Robotic central pancreatectomy (CP) has emerged in recent years as a noninferior approach to open CP and may offer improved patient-reported outcomes and reduction in incisional hernias.
METHODS METHODS
All patients who underwent open and robotic CP between (2013 and 2022) were selected, and perioperative outcomes were analyzed. Patients who underwent robotic CP were interviewed over the phone to assess patient-reported postoperative outcomes.
RESULTS RESULTS
A total of 18 CP operations (56%-open vs. 44%-robotic) were identified. The overall median age was 67 years (interquartile range: 60-72), and 50% (n = 9) of patients were female. Median length of surgery was statistically longer for robotic CP (411 vs. 138 min, p = 0.002); all other intraoperative variables were similar. Postoperatively, a similar number of patients in the open and robotic cohorts developed clinically significant postoperative pancreatic fistulas (37.5% vs. 30%, p = 1) and major complications (37.5% vs. 20%, p = 0.60), respectively. No patients in the robotic cohort developed an incisional hernia, compared to 40% (n = 4) in open (p = 0.08). All patients returned to a baseline level of activity and reported a high quality of life.
CONCLUSION CONCLUSIONS
With the exception of longer operative times, robotic CP is a noninferior, definitive resection technique for select lesions of the middle pancreas. Additionally, the robotic approach may result in a reduction in incisional hernia development.

Identifiants

pubmed: 37021327
doi: 10.1002/jso.27266
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-57

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Iacono C. Central pancreatectomy: the Dagradi Serio Iacono operation. Evolution of a surgical technique from the pioneers to the robotic approach. World J Gastroenterol. 2014;20:15674.
Giulianotti PC, Sbrana F, Bianco FM, Addeo P, Caravaglios G. Robot-assisted laparoscopic middle pancreatectomy. J Laparoendosc Adv Surg Tech A. 2010;20:135-139.
Abood GJ, Can MF, Daouadi M, et al. Robotic-assisted minimally invasive central pancreatectomy: technique and outcomes. J Gastrointest Surg. 2013;17:1002-1008.
Cheng K, Shen B, Peng C, Deng X, Hu S. Initial experiences in robot-assisted middle pancreatectomy. HPB. 2013;15:315-321.
Chen S, Zhan Q, Jin J, et al. Robot-assisted laparoscopic versus open middle pancreatectomy: short-term results of a randomized controlled trial. Surg Endosc. 2017;31:962-971.
Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. JCE. 1994;47:1245-1251.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(161):584-591.
Winer J, Can MF, Bartlett DL, Zeh HJ, Zureikat AH. The current state of robotic-assisted pancreatic surgery. Nat Rev Gastroenterol Hepatol. 2012;9:468-476.
Kang CM, Kim DH, Lee WJ, Chi HS. Initial experiences using robot-assisted central pancreatectomy with pancreaticogastrostomy: a potential way to advanced laparoscopic pancreatectomy. Surg Endosc. 2011;25:1101-1106.
Zureikat AH, Moser AJ, Boone BA, Bartlett DL, Zenati M, Zeh HJ. 250 robotic pancreatic resections: safety and feasibility. Ann Surg. 2013;258:554-562.
Cirocchi R, Partelli S, Coratti A, Desiderio J, Parisi A, Falconi M. Current status of robotic distal pancreatectomy: a systematic review. Surg Oncol. 2013;22:201-207.
Alfieri S, Boggi U, Butturini G, et al. Full robotic distal pancreatectomy: safety and feasibility analysis of a multicenter cohort of 236 patients. Surg Innov. 2020;27:11-18.
Bartels SAL, Vlug MS, Hollmann MW, et al. Small bowel obstruction, incisional hernia and survival after laparoscopic and open colonic resection (LAFA study). Br J Surg. 2014;101:1153-1159.
Pecorelli N, Greco M, Amodeo S, Braga M. Small bowel obstruction and incisional hernia after laparoscopic and open colorectal surgery: a meta-analysis of comparative trials. Surg Endosc. 2017;31:85-99.
Kössler-Ebs JB, Grummich K, Jensen K, et al. Incisional hernia rates after laparoscopic or open abdominal surgery-a systematic review and meta-analysis. World J Surg. 2016;40:2319-2330.
Paiella S, De Pastena M, Faustini F, et al. Central pancreatectomy for benign or low-grade malignant pancreatic lesions-a single-center retrospective analysis of 116 cases. Eur J Surg Oncol. 2019;45:788-792.
Goudard Y, Gaujoux S, Dokmak S, et al. Reappraisal of central pancreatectomy: a 12-year single-center experience. JAMA Surg. 2014;149:356-363.
Xiao W, Zhu J, Peng L, Hong L, Sun G, Li Y. The role of central pancreatectomy in pancreatic surgery: a systematic review and meta-analysis. HPB. 2018;20:896-904.
Ocuin LM, Sarmiento JM, Staley CA, et al. Comparison of central and extended left pancreatectomy for lesions of the pancreatic neck. Ann Surg Oncol. 2008;15:2096-2103.

Auteurs

Pranay S Ajay (PS)

Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

Nina L Eng (NL)

Department of General Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.

Caitlin P Sok (CP)

Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

Danielle E Mustin (DE)

Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia, USA.

Kenneth Cardona (K)

Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

Juan M Sarmiento (JM)

Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

Mihir M Shah (MM)

Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

Maria C Russell (MC)

Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

Shishir K Maithel (SK)

Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

David A Kooby (DA)

Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH